Gilead Sciences Inc
Stock Chart, Company Information, and Scan Results
$121.20(as of Dec 8, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Gilead Sciences Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$121.20
Ticker SymbolGILD
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees17,600
CountyUSA
Market Cap$150,410.6M
EBIDTA14,136.0M
10-Day Moving Average124.40
P/E Ratio18.74
20-Day Moving Average124.47
Forward P/E Ratio12.76
50-Day Moving Average120.82
Earnings per Share6.46
200-Day Moving Average112.13
Profit Margin39.28%
RSI44.51
Shares Outstanding1,240.7M
ATR2.83
52-Week High128.70
Volume8,203,519
52-Week Low86.73
Book Value21,456.0M
P/B Ratio7.08
Upper Keltner130.82
P/S Ratio5.22
Lower Keltner118.11
Debt-to-Equity Ratio130.82
Next Earnings DateUnknown
Cash Surplus-4,967.0M
Next Ex-Dividend Date12/15/2025
Add good karma to your portfolio with GILD. This research-based biopharmaceutical company is making the world a better place by developing and commercializing medicines for life-threatening diseases like HIV/AIDS, liver diseases, and cancer. Gilead’s HIV treatments, including Truvada and Atripla, have helped transform the chronic disease into a manageable condition. Their treatments are responsible for saving millions of lives.
Gilead Sciences Inc In Our Stock Scanner
As of Dec 09, 2025
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.